FNKCX
Price
$14.06
Change
-$0.04 (-0.28%)
Updated
Sep 20 closing price
VMVAX
Price
$86.17
Change
-$0.37 (-0.43%)
Updated
Sep 20 closing price
Ad is loading...

FNKCX vs VMVAX

Header iconFNKCX vs VMVAX Comparison
Open Charts FNKCX vs VMVAXBanner chart's image
Frank Value C
Price$14.06
Change-$0.04 (-0.28%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$86.17
Change-$0.37 (-0.43%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FNKCX vs VMVAX Comparison Chart
Loading...
VS
FNKCX vs. VMVAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FNKCX is a Buy and VMVAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.5B vs. FNKCX (20.9M). VMVAX pays higher dividends than FNKCX: VMVAX (2.14) vs FNKCX (1.78). FNKCX was incepted earlier than VMVAX: FNKCX (14 years) vs VMVAX (13 years). FNKCX is a more actively managed with annual turnover of: 109.16 vs. VMVAX (22.00). FNKCX has a lower initial minimum investment than VMVAX: FNKCX (1500) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 25.35 vs. FNKCX (11.10). VMVAX return over 5 years is better than : 48.82 vs. FNKCX (27.69).
FNKCXVMVAXFNKCX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years13 years-
Gain YTD10.27514.94669%
Front LoadN/AN/A-
Min. Initial Investment1500300050%
Min. Initial Investment IRAN/AN/A-
Net Assets20.9M30.5B0%
Annual Yield % from dividends1.782.1483%
Returns for 1 year11.1025.3544%
Returns for 3 years8.0720.7139%
Returns for 5 years27.6948.8257%
Returns for 10 years1.45100.881%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUUD0.790.01
+0.67%
Auddia
CTLT60.00-0.11
-0.18%
CATALENT
JAMF18.49-0.09
-0.48%
Jamf Holding Corp
ARCT20.61-0.41
-1.95%
Arcturus Therapeutics Holdings
ANVS8.47-0.17
-1.97%
Annovis Bio